Market Analysis - Journal of Evolutionary Medicine ( 2021) Volume 9, Issue 3
Embryology 2020_Market AnalysisPablo Galvis Centurion*
Pablo Galvis Centurion, Department of Gynecologist, Colombia, Email: firstname.lastname@example.org
IVF is a type of assisted reproductive technology used for infertility treatment and gestational surrogacy in which a fertilized egg is implanted into a surrogate's uterus, and the resulting child is genetically unrelated to the surrogate. Some countries banned or otherwise regulate the availability of IVF treatment giving rise to fertility tourism. Restrictions on the availability of IVF include costs and age to carry a healthy pregnancy to term. IVF is mostly attempted if less invasive or expensive options have failed or are unlikely to work.
Embryology is characterized by the process of cell division and cellular differentiation of the embryo that occurs during the early stages of development. Embryogenesis covers the first eight weeks of development; at the beginning of the ninth week, the embryo is termed a fetus. Human embryology is the study of this development during the first eight weeks after fertilization. The new embryology Technics supports to provide practical information that is to assisted reproduction, early birth, birth defects, stem cell therapy, fetal surgery, and other fields.
Embryology has become an important research area for studying the genetic control of the development process, its link to cell signaling, its importance for the study of certain diseases and mutations, and in links to stem cell research. As defined by WHO, infertility is a complex pathology that requires appropriate investigation and treatment. One of the most effective treatments is IVF and its related technologies these techniques cannot be replaced by other procedures and have resulted in the birth of more than 6 million babies throughout the world.
Glance at Market of Embryology:
The world’s leading Embryology market has attracted the rising use of intra-cytoplasmic sperm injection (ICSI) for the treatment of infertility. The report in Human Reproduction shows that while ICSI use has leveled off in some regions, its use is approaching 100% of assisted reproduction cycles in the Middle East and a few countries in other regions, despite the fact that ICSI was developed for the treatment of male infertility, which is a factor in around 40% of couples seeking fertility treatment.
The global fertility testing devices market is broadly categorized into ovulation prediction kits and fertility monitors. The fertility monitors segment includes saliva-based monitors, urine-based monitors and others. The ovulation prediction kits market held the larger share of the global fertility testing devices market in 2015. However, the fertility monitors market is estimated to grow at the higher CAGR from 2015 to 2020. The average cost of in vitro fertilization in the U.S. is currently about $11,000 to $12,000.